Human milk contains many bioactive components, including secretory IgA, oligosaccharides, and milkassociated proteins. We assessed the antiviral effects of several components of milk against mammalian reoviruses. We found that glucocerebroside (GCB) inhibited the infectivity of reovirus strain type 1 Lang (T1L), whereas gangliosides GD3 and GM3 and 3 0 -sialyllactose (3SL) inhibited the infectivity of reovirus strain type 3 Dearing (T3D). Agglutination of erythrocytes mediated by T1L and T3D was inhibited by GD3, GM3, and bovine lactoferrin. Additionally, a-sialic acid, 3SL, 6 0 -sialyllactose, sialic acid, human lactoferrin, osteopontin, and a-lactalbumin inhibited hemagglutination mediated by T3D. Using single-gene reassortant viruses, we found that serotype-specific differences segregate with the gene encoding the viral attachment protein. Furthermore, GD3, GM3, and 3SL inhibit T3D infectivity by blocking binding to host cells, whereas GCB inhibits T1L infectivity post-attachment. These results enhance an understanding of reovirus cell attachment and define a mechanism for the antimicrobial activity of human milk.
Introduction
Several components of human milk protect against infection by many pathogens. For example, IgA and IgG contained in human milk play important roles in mucosal immune protection of infants and have activity against several viruses including enteroviruses, herpesviruses, norovirus, reovirus, respiratory syncytial virus, rotavirus, and rubella virus (Jiang et al., 2004; Lawrence and Pane, 2007) . Human milk oligosaccharides protect against infectious diarrhea , and milk-associated proteins have antiviral effects against adenovirus (Arnold et al., 2002) , human papillomavirus (Mistry et al., 2007) , poliovirus (Marchetti et al., 1999) , and rotavirus (Yolken et al., 1987) . However, mechanisms by which human milk exerts its antiviral activities have not been fully defined.
Reovirus is a member of the Reoviridae and serves as an important experimental model for studies of virus-receptor interactions and viral pathogenesis (Danthi et al., 2010) . Reovirus attachment occurs by a multistep adhesion-strengthening process in which viral attachment protein s1 first binds to an abundant cell-surface carbohydrate with low affinity (Barton et al., 2001b) , followed by high-affinity interactions with junctional adhesion molecule-A (JAM-A) (Barton et al., 2001c (Barton et al., , 2001a . Although the carbohydrate bound by serotype 1 reovirus has not been conclusively identified, serotype 3 reovirus binds to a-linked sialic acid (SA) (Dermody et al., 1990; Gentsch and Pacitti, 1985; Paul et al., 1989; Reiter et al., 2011) .
Following intramuscular inoculation of newborn mice, prototype reovirus strains type 1 Lang (T1L) and type 3 Dearing (T3D) disseminate to the central nervous system. However, these strains use different routes of spread and produce distinctly different diseases. T1L spreads hematogenously (Antar et al., 2009; Boehme et al., 2009; Tyler et al., 1986) and causes hydrocephalus (Weiner et al., 1977) , whereas T3D spreads by both hematogenous and neural routes (Boehme et al., 2011) and causes encephalitis (Weiner et al., 1977) . These strain-specific differences in mode of spread (Tyler et al., 1986) and cell tropism in the central nervous system (Dichter and Weiner, 1984; Weiner et al., 1977) segregate with the S1 gene segment, which encodes viral attachment protein s1 (Lee et al., 1981; Weiner et al., 1980) . These observations suggest that receptor recognition by reovirus strongly influences pathogenesis in infected mice. The s1 molecule is a trimer approximately 480Å in length composed of a filamentous N-terminal tail and a globular C-terminal head (Fraser et al., 1990; Furlong et al., 1988) . Reovirus s1 shares striking structural similarities with the adenovirus attachment protein, fiber (Stehle and Dermody, 2003) . Each protein forms a trimer with a tail that partially inserts into the virion at the icosahedral vertices and a head that projects away from the virion surface. Both s1 and fiber possess an uncommon triple b-spiral fold in the tail and an eight-stranded b-barrel structure that forms the head. Discrete regions of reovirus s1 mediate binding to cellsurface receptors. Sequences in the tail of serotype 3 reovirus bind to SA (Chappell et al., 1997; 2000; Dermody et al., 1990; Reiter et al., 2011) , while sequences in the head of both serotype 1 and serotype 3 reovirus bind to JAM-A (Barton et al., 2001c; Schelling et al., 2007) . Serotype 1 reovirus does not have carbohydratebinding sequences in an analogous region in the tail (Chappell et al., 2000) . The physiological significance of differential glycan utilization by the reovirus serotypes is unknown.
To enhance an understanding of the antiviral effects of milk, we tested components of both human and bovine milk for the capacity to inhibit the infectivity of reovirus strains T1L and T3D. We found that several milk constituents display strain-specific differences in inhibition of infectivity and erythrocyte binding, a surrogate for glycan engagement. We determined that these differences segregate with the s1-encoding S1 gene segment.
Furthermore, we show that gangliosides GD3 and GM3 as well as 3 0 -sialyllactose (3SL) inhibit T3D attachment to cells and provide evidence for blockade of cell binding as an antiviral mechanism for certain human milk components.
Results

Cytotoxicity of milk components
To define non-cytotoxic concentrations of milk components, we monitored the capacity of either HeLa S3 (HeLa) cells or L929 (L) cells to reduce 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS). Cells were incubated with milk components, washed, and incubated for 16-18 h with methyl cellulose medium. Cells were incubated with MTS, and reduction of MTS (quantified by absorbance at 490 nm) was used as a surrogate for cell viability. Concentrations of milk components that resulted in absorption of less than 50% of the absorption of mock-treated cells were considered cytotoxic. At the highest concentrations tested, n-acetylneuraminic acid (SA) was cytotoxic in both HeLa cells (Fig. 1A ) and L cells (Fig. 1B) . The cytotoxic concentration of SA was comparable in both HeLa cells and L cells. GD3 was cytotoxic at the highest concentration tested in L cells, and a-lactalbumin (aLB) was cytotoxic at the highest concentration tested in HeLa cells. At all concentrations tested, a-sialyllactose (aSL), 3SL, 6'-sialyllactose (6SL), a-lactose monohydrate (LAC), bovine lactoferrin (bLF), human lactoferrin (hLF), osteopontin (OSP), bovine lactoferricin (bLFC), and human lactoferricin (hLFC) were not cytotoxic in either HeLa cells (Fig. 1A ) or L cells (Fig. 1B) . Inhibition of reovirus infectivity by milk components was assessed using concentrations that were less than the cytotoxic concentrations observed following treatment of HeLa cells or L cells.
Inhibition of reovirus infectivity by milk components
To determine whether milk components inhibit the infectivity of reovirus strain T1L, components were preincubated with virus, and either HeLa cells or L cells were inoculated with the virus-component mixture. Infectivity was determined using an imager-based immunofluorescence infectivity assay (Iskarpatyoti et al., 2012) , and results were compared to a mock-treated virus control. glucocerebroside (GCB) was the only milk component tested that inhibited T1L infectivity (Fig. 2) . The related gangliosides GD3 and GM3 did not inhibit T1L infection of either HeLa cells ( Fig. 2A ) or L cells (Fig. 2B) . As a positive control, T1L s1-specific monoclonal antibody (mAb) 5C6 potently inhibited T1L (Virgin et al., 1991) .
To determine whether milk components inhibit the infectivity of reovirus strain T3D, components were preincubated with virus, and HeLa cells or L cells were inoculated with the viruscomponent mixture. Infectivity was similarly determined by immunofluorescence, and results were compared to a mocktreated virus control. GD3, GM3, and 3SL inhibited T3D infectivity in both HeLa cells (Fig. 3A) and L cells (Fig. 3B) . No significant inhibition was observed following incubation of T3D with 6SL.
aSL, which is a mixture of 3SL and 6SL, resulted in an intermediate level of inhibition of T3D infectivity in both HeLa cells and L cells, but the effect was not statistically significant. The remaining components had no effect on T3D infectivity (data not shown). As a positive control, T3D s1-specific mAb 9BG5 potently inhibited T3D infectivity (Burstin et al., 1982) .
Inhibition of reovirus hemagglutination by milk components
To determine whether milk components are capable of inhibiting reovirus hemagglutination (HA), HA inhibition (HAI) assays were performed using component-pretreated T1L and T3D. GD3, GM3, and bLF inhibited T1L-mediated HA of human erythrocytes (Fig. 4A ). GD3 and GM3 were the most potent, requiring the lowest concentrations to inhibit HA. The lowest concentrations that inhibited T1L HA (HAI concentrations) for bLF were more than 10-fold greater than the HAI concentrations observed for GD3 and GM3 (Fig. 4C ). GCB and the remaining milk components tested did not inhibit HA by T1L at any concentration tested (Fig. 4A ). In contrast, GD3, GM3, aSL, 3SL, 6SL, SA, bLF, hLF, OSP, and aLB inhibited T3D-mediated HA of bovine erythrocytes (Fig. 4B ). Both GD3 and GM3 potently inhibited T3D HA. The HAI concentration of OSP was nearly 4-fold greater than the HAI concentrations of GD3 and GM3.
The HAI concentrations of hLF and aLB were each approximately 4-fold greater than the HAI concentration of OSP. The HAI concentration of bLF was approximately 25-fold greater than the HAI concentration of hLF. Finally, SA was the least potent inhibitor of T3D HA, with an HAI concentration 4-fold greater than that of aSL, 3SL, and 6SL, and more than 140,000-fold greater than the HAI concentration of GD3 (Fig. 4D) . GCB, LAC, bLFC, and hLFC did not inhibit HA by T3D at any concentration tested (Fig. 4B) . As negative controls, neither phosphate-buffered saline (PBS) ( Fig. 4A and B, PBS) nor milk components (Figs. 4A-C) produced HA. Dimethyl sulfoxide did not affect reovirus agglutination of red blood cells ( Fig. 4A and B, DMSOþV) and did not produce HA at concentrations less than a 50:50 (v/v) mixture with PBS ( Fig. 4A and B, DMSO). As positive controls, serial dilutions of virus in PBS were capable of agglutinating red blood cells until a threshold of 3.9 Â 10 8 particles for T1L (defined as 1 HA unit for T1L) and 3.1 Â 10 9 particles for T3D
(defined as 1 HA unit for T3D) (Figs. 4A and B, V).
The reovirus S1 gene segment determines strain-specific differences in hemagglutination
Since HA is mediated by s1 binding to erythrocyte glycans (Chappell et al., 1997 (Chappell et al., , 2000 Weiner et al., 1978) , we hypothesized that milk components capable of inhibiting HA do so by blocking interactions with s1. To test this hypothesis, we assessed milk component inhibition of HA mediated by reovirus strains rs1HA3 and rs3HA1. Strain rs1HA3 contains nine gene segments from T1L and the S1 gene segment from T3D, whereas rs3HA1 contains nine gene segments from T3D and the S1 gene segment from T1L
( Fig. 5A ). GD3, GM3, aSL, 3SL, and 6SL each inhibited HA mediated by rs1HA3 (Fig. 5B ), similar to our findings with T3D ( Fig. 4B ).
As anticipated from our studies using T3D, both GD3 and GM3 potently inhibited rs1HA3-mediated HA. The HAI concentrations of GD3 and GM3 for rs1HA3 were approximately 4-fold and 18-fold greater, respectively, compared to the HAI concentrations of these components for T3D. The HAI concentrations of aSL, 3SL, and 6SL for rs1HA3 were comparable to those for T3D (Figs. 4D and 5D) . Only GD3 and GM3 inhibited HA mediated by rs3HA1, similar to our findings with T1L (Fig. 4A ). The rs3HA1 HAI concentrations for GD3 and GM3 were comparable to the T1L HAI concentrations for GD3 and GM3 (Figs. 4C, 5E ). As a positive control, 9BG5 inhibited HA mediated by rs1HA3 but not rs3HA1, whereas 5C6 inhibited HA mediated by rs3HA1 but not rs1HA3. Thus, strain-specific differences in HAI capacity of milk components segregate with the reovirus S1 gene segment.
The reovirus S1 gene segment determines strain-specific differences in inhibition of infectivity Since GD3, GM3, aSL, 3SL, and 6SL contain SA, which is a receptor for serotype 3 reoviruses (Barton et al., 2001b; Gentsch and Pacitti, 1985; Paul et al., 1989) , we hypothesized that inhibition of reovirus infectivity by these components should be strain-specific. To test this hypothesis, GCB, GD3, GM3, aSL, 3SL, and 6SL were preincubated with either rs1HA3 or rs3HA1, and L cells were inoculated with each virus-component mixture. Infectivity was determined by immunofluorescence, and results were compared to a mock-treated virus control. GD3, GM3, and 3SL inhibited 1HA3 infectivity (Fig. 6A ), as these compounds did for T3D (Fig. 3) . Only GCB was capable of inhibiting 3HA1 infectivity (Fig. 6B) , as it did for T1L (Fig. 2) . Thus, strain-specific differences in inhibition of reovirus infectivity by milk components segregate with the reovirus S1 gene segment (Fig. 7) . Wells with uninfected cells stained with secondary antibody and without cell stains served as a background control. Plate images were captured using a LI-COR imager and analyzed with Odyssey v 3.0 software. Relative intensity was determined by normalizing the intensity of the signal in the 800 nm channel (anti-reovirus) to the intensity of the signal in the 700 nm channel (cell stains) for each well. Relative intensity values are expressed as mean percentage of untreated virus (T1L control) for three independent experiments. Error bars represent SD. The mAb 5C6 (concentration based on estimated molecular weight) was used as a positive-inhibitor control. *, P o 0.05 by one-way ANOVA. Wells with uninfected cells stained with secondary antibody and without cell stains served as a background control. Plate images were captured using a LI-COR imager and analyzed with Odyssey v 3.0 software. Relative intensity was determined by normalizing the intensity of the signal in the 800 nm channel (anti-reovirus) to the intensity of the signal in the 700 nm channel (cell stains) for each well. Relative intensity values are expressed as mean percentage of untreated virus (T3D control) for three independent experiments. Error bars represent SD. The mAb 9BG5 (concentration based on estimated molecular weight) was used as a positive-inhibitor control. *, P o 0.05 by one-way ANOVA.
GD3, GM3, and 3SL inhibit T3D infectivity by blocking attachment to cells
Since the inhibition of reovirus infectivity by milk components segregates with the s1-encoding S1 gene segment, we hypothesized that infection-blocking components would inhibit reovirus binding to cells. To test this hypothesis, we adsorbed HeLa cells with either T1L or T3D preincubated with milk components at 4 1C for 1 h to minimize internalization. Binding was quantified using flow cytometry, and results were compared to mocktreated virus. GD3, GM3, and 3SL inhibited T3D binding to HeLa cells, whereas GCB did not. Interestingly, GCB, which inhibits T1L infectivity, did not inhibit T1L binding to HeLa cells, suggesting that GCB inhibits T1L infectivity by altering a s1 function that is operant following viral attachment.
Discussion
In this study, we found that serotype-specific differences in inhibition of reovirus infectivity by the milk components GCB, GD3, GM3, and 3SL are determined by the viral S1 gene segment. The infectivity of both T1L and rs3HA1 was inhibited by GCB at similar doses but not by GD3, GM3, or 3SL. In contrast, the infectivity of both T3D and rs1HA3 was inhibited by GD3, GM3, and 3SL at similar doses but not by GCB. Furthermore, reovirus HA, which is dependent on s1 binding to glycans on the erythrocyte surface (Chappell et al., 1997 (Chappell et al., , 2000 Weiner et al., 1978) , was inhibited by milk components. Serotype-specific differences in inhibition by aSL, 3SL, and 6SL, which only inhibited HA mediated by T3D and rs1HA3, were also determined by the S1 gene segment. Finally, we found that GD3, GM3, and 3SL inhibited T3D infectivity by blocking virus attachment to cells. In contrast, GCB, which did not inhibit reovirus HA by either serotype, did not block T1L cell attachment, suggesting that GCB blocks a post-attachment step in T1L infection that is determined by the S1 gene segment. The results are summarized in Table 1 .
The T3D s1 protein binds to a-linked SA (Dermody et al., 1990; Gentsch and Pacitti, 1985; Paul et al., 1989; Reiter et al., 2011) . All of the milk-associated glycans used in our study that contain a terminal SA, including GD3, GM3, aSL, 3SL, 6SL, and SA, inhibited HA mediated by T3D and rs1HA3. However, while a terminal SA is sufficient to inhibit HA mediated by serotype 3 reoviruses, the potency of the effect is increased by larger compounds, possibly via interactions of non-SA moieties of the compound with the s1 protein (Reiter et al., 2011) . Interestingly, only GD3, GM3, and 3SL were capable of inhibiting infection of HeLa cells and L cells by T3D and rs1HA3. Of these compounds, GD3 and GM3 were substantially more potent inhibitors of T3D infectivity than 3SL, with minimum inhibitory concentrations in the micromolar range for GD3 and nanomolar range for GM3.
Since the affinity of s1 for SA is in the millimolar range (Reiter et al., 2011) , and the glycan component of GM3 is identical to 3SL, we think it likely that multivalent interactions as a consequence of micelles formed by the lipid portions of the gangliosides explain the much greater inhibitory potency of GD3 and GM3 in comparison to the free glycans.
The SA-containing milk-associated proteins bLF, hLF, OSP, and aLB inhibit HA mediated by T3D and rs1HA3. However, these components did not inhibit infection of either HeLa cells or L cells by T3D or rs1HA3. These data suggest that although HA mediated by T3D and rs1HA3 is dependent on SA binding, infection of HeLa cells and L cells by these viruses is less dependent on binding to this carbohydrate. These results are consistent with previous studies indicating that a non-SA-binding serotype 3 reovirus strain can infect both HeLa cells and L cells (Barton et al., 2001b; Connolly et al., 2001) . It is possible that the glycans capable of inhibiting infectivity bind to s1 with higher relative affinity and thus diminish the adhesion strengthening required for s1 to efficiently engage JAM-A. Since HA is completely dependent on glycan binding, even SA-containing compounds that bind s1 with lower relative affinity appear to be capable of blocking reovirus interactions with erythrocytes.
Although the carbohydrate bound by T1L s1 has not been conclusively identified, both GD3 and GM3 inhibited HA mediated by T1L and rs3HA1, suggesting that T1L s1 engages SA-containing glycans in some contexts. Concordantly, GCB, which does not contain SA, was not capable of inhibiting HA mediated by either serotype 1 reovirus strain. However, the other SA-containing compounds did not inhibit HA mediated by T1L, suggesting that T1L s1 binds to terminal SA residues only on some types of carbohydrates. In contrast, GCB but not GD3 or GM3 inhibited infection of HeLa cells and L cells by T1L and 3HA1. These results are surprising because GD3 and GM3 both contain the GCB moiety. It is possible that engagement of T1L s1 by GD3 or GM3 is not of sufficient affinity to impede subsequent interactions with JAM-A, analogous to SA-containing compounds that inhibit T3D HA but not T3D infectivity. We think GCB inhibits T1L
infection by blocking a s1 function independent of glycan binding, perhaps interfering with JAM-A binding or impeding conformational changes in s1 during viral disassembly. The mechanism by which GCB blocks T1L infection is a focus of ongoing work. GCB, GD3, and GM3 are components that are differentially expressed on cell surfaces. Therefore, these cell-surface molecules may facilitate viral attachment and entry. Furthermore, it is possible that interactions with GCB, GD3, and GM3 contribute to differences in the pathogenesis of serotype 1 and serotype 3 reoviruses in infected animals. Future studies using an in vivo model could help elucidate the role that these molecules play in pathogenesis and tropism.
Infectivity of several viruses can be inhibited by milk-associated glycans, including human immunodeficiency virus, influenza virus, norovirus, polyomavirus, and rotavirus . The mechanisms by which these glycans inhibit viral replication have not been fully defined. In addition, the antiviral capacities of many milk components are still being explored. Results of this study provide evidence that inhibition of virus attachment to cells is an antiviral mechanism of at least some human milk glycans. Moreover, the identification of milk components that inhibit viral replication may aid in selecting supplements for inclusion in infant formulations of human milk and enhance an understanding of virus-glycan interactions.
Materials and methods
Cells, viruses, and antibodies
HeLa cells were maintained in Dulbecco's modified Eagle's minimum essential medium (MEM) (Invitrogen, Carlsbad, CA, USA) supplemented to contain 10% heat-inactivated fetal bovine serum (FBS), 2 mM l-glutamine, 100 U/mL penicillin, 100 mg/mL streptomycin (Invitrogen), and 25 ng/mL amphotericin B (SigmaAldrich, St. Louis, MO, USA). Spinner-adapted murine L cells were grown in suspension culture in Joklik's modified Eagle's MEM (Lonza, Basel, Switzerland) supplemented to contain 5% FBS, 2 mM Fig. 6 . The reovirus S1 gene segment determines strain-specific differences in inhibition of infectivity. Strains rs1HA3 (A) and rs3HA1 (B) were preincubated at RT for 1 h with serial dilutions of GCB, GD3, GM3, aSL, 3SL, and 6SL. L cells were adsorbed with component-preincubated virus at an MOI of 50 PFU/cell at RT for 1 h and incubated at 37 1C for 16-18 h. Cells were fixed and stained with rabbit anti-reovirus serum, followed by goat anti-rabbit 800 IRDye s CW-labeled secondary antibody and Draq5 TM and Sapphire 700 TM cell stains. Wells with uninfected cells and stained with secondary antibody and without cell stains served as a background control. Plate images were captured using a LI-COR imager and analyzed with Odyssey v 3.0 software. Relative intensity was determined by normalizing the intensity of the signal in the 800 nm channel (anti-reovirus) to the intensity of the signal in the 700 nm channel (cell stains) for each well.
Relative intensity values are expressed as mean percentage of mock-treated virus (1HA3 control and 3HA1 control) for three independent experiments. Error bars represent SD. The mAb 9BG5 was used as a positive-inhibitor control for 1HA3, and the mAb 5C6 was used as a positive-inhibitor control for 3HA1. *,Po 0.05 by one-way ANOVA. were preincubated at RT for 1 h with GCB (60 mM), GD3 (30 mM), GM3 (30 mM), 3SL (5000 mM), or mAb 5C6 (0.03 mM). HeLa cells were adsorbed with 10 5 particles component-preincubated virus/cell at 4 1C for 1 h. Cells were stained with rabbit anti-reovirus serum, followed by goat anti-rabbit 546 Alexa Fluor secondary antibody. Cells were fixed in PBS containing 1% paraformaldehyde. Fluorescence intensity was quantified using a BD LSRII flow cytometer, and results were analyzed using FlowJo software. Results are expressed as a normalized mean fluorescence intensity of three independent experiments. Error bars represent SD. The mAb 5C6 was used as a positive-inhibitor control for T1L. *,Po 0.05 by oneway ANOVA.
l-glutamine, 100 U/mL penicillin, 100 mg/mL streptomycin, and 25 ng/mL amphotericin B. Laboratory stocks of reovirus strains T1L and T3D were generated using twice-plaque-purified isolates of each strain (Furlong et al., 1988) . Strains rs1HA3, which contains nine gene segments from T1L and the S1 gene segment from T3D, and rs3HA1, which contains nine gene segments from T3D and the S1 gene segment from T1L, were generated using plasmid-based reverse genetics (Kobayashi et al., 2007 (Kobayashi et al., , 2010 . Virus particles were purified by CsCl gradient centrifugation (Smith et al., 1969) . Viral titers were determined by plaque assay using L cells (Virgin et al., 1988) . The genotypes of T1L, T3D, rs1HA3, and rs3HA1 were confirmed by electrophoresis of viral particles in 4-20% gradient sodium dodecyl sulfate polyacrylamide gels. Gels were stained with ethidium bromide, and gene segments were visualized by UV-illumination (Wilson et al., 1996) .
Reovirus serotype-specific neutralizing mAbs 5C6 (Virgin et al., 1991) and 9BG5 (Burstin et al., 1982) were obtained from the Developmental Studies Hybridoma Bank (Iowa City, Iowa, USA).
Milk components
GD3, GM3, and GCB were purchased from Matreya, LLC (Pleasant Gap, PA, USA) and suspended in DMSO. aSL, SA, LAC, hLF, aLB, bLFC, and hLFC were purchased from Sigma-Aldrich. 3SL, 6SL, and bLF were obtained from Pfizer Nutrition (Collegeville, PA, USA). OSP was purchased from R&D Systems (Minneapolis, MN, USA). Milk components other than GD3, GM3, and GCB were suspended in Dulbecco's PBS without calcium or magnesium (Invitrogen).
Cytotoxicity assay
The maximum non-cytotoxic concentration of milk components was established using the CellTiter 96 AQ ueous assay (Promega, Madison, WI, USA), which is based on the capacity of viable cells to metabolically reduce MTS. Confluent monolayers of HeLa cells or L cells were adsorbed with 2-fold dilutions of each milk component in PBS at room temperature (RT) for 1 h. Cells were washed with PBS, overlayed with methyl cellulose medium, and incubated at 37 1C for 16-18 h. MTS was added to cells according to the manufacturer's instructions. Following incubation at 37 1C for 3 h, absorbance was determined using a BioTek Synergy H1 Hybrid Reader (Winooski, VT, USA) at 490 nm. Absorbance of treated cells was compared to absorbance of untreated cells as controls.
Imager-based infectivity inhibition assay
Confluent monolayers of HeLa cells or L cells were adsorbed at an MOI of 50 PFU/cell with purified reovirus virions preincubated with 10-fold dilutions of milk components at RT for 1 h. Infected cells were incubated at RT for 1 h, overlayed with methyl cellulose medium, and incubated at 37 1C for 16-18 h. Cells were fixed and stained with rabbit anti-reovirus serum, followed by goat anti-rabbit 800 IRDye s CW-labeled secondary antibody and Draq5 TM and Sapphire 700 TM cell stains (Iskarpatyoti et al., 2012) .
Wells with cells only, stained with secondary antibody and without cell stains, served as a background control. Plate images were captured using a LI-COR imager and analyzed with Odyssey v 3.0 software (LI-COR, Lincoln, NE, USA).
Hemagglutination inhibition assay
HA titers of T1L and rs3HA1 were determined using human erythrocytes, and those of T3D and rs1HA3 were determined using bovine erythrocytes (Lerner et al., 1962) . Purified virions (4 HA units) were pretreated with 2-fold dilutions of milk components in PBS at RT for 1 h. Bovine erythrocytes (Colorado Serum, Denver, CO, USA) and type O-positive human erythrocytes (Vanderbilt University Medical Center Blood Bank, Nashville, TN, USA) were washed with PBS until the supernatant was clear and resuspended to 1% (vol/vol) in PBS. Milk component-pretreated T1L and rs3HA1 were incubated with human erythrocytes and milk component-pretreated T3D and rs1HA3 were incubated with bovine erythrocytes at 4 1C for 3 h. The HAI concentration was determined for each milk component and is defined as the lowest concentration of component capable of inhibiting virus-induced HA (Burstin et al., 1982; Virgin et al., 1991) .
Flow cytometery
Monolayers of HeLa cells were washed with PBS and detached from a plate using Cellstripper (Cellgro, Manassas, VA, USA) at 37 1C. Cellstripper was quenched with fluorescence-activated cell sorter (FACS) buffer (PBS with 2% FBS), and cells were pelleted at 1000g, washed once with PBS, and pelleted again at 1,000g. Cells were adsorbed at 4 1C for 1 h with 10 5 particles of reovirus/cell that had been preincubated with milk components at a concentration sufficient to produce maximum infectivity inhibition. After adsorption, cells were washed once in FACS buffer, pelleted at 1000g, and stained in FACS buffer containing rabbit antireovirus serum at 4 1C for 30 min. Cells were washed twice in FACS buffer, pelleted at 1000g, and stained in FACS buffer containing goat anti-rabbit 546 Alexa Fluor secondary antibody at 4 1C for 30 min. Cells were washed twice in FACS buffer and fixed in PBS containing 1% electron microscopy grade paraformaldehyde (Electron Microscopy Sciences, Hatfield, PA, USA). Virus-bound cells were quantified using a BD LSRII flow cytometer (BD Biosciences, San Jose, California, USA), and results were analyzed using FlowJo software.
